Viracta(VIRX) - 2019 Q2 - Earnings Call Transcript

Sunesis Pharmaceuticals, Inc. (SNSS) Q2 2019 Earnings Conference Call August 7, 2019 4:30 PM ET Company Participants Willie Quinn - Chief Financial Officer & Senior Vice President, Corporate Development Dayton Misfeldt - Interim Chief Executive Officer Judy Fox - Chief Scientific Officer Par Hyare - Senior Vice President Commercial Deepali Suri - Vice President, Clinical Operations Conference Call Participants Marc Frahm - Colin Hartaj Singh - Oppenheimer Jim Birchenough - Wells Fargo Securities Yanan Zhu - ...